Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine

Transplantation

Volumn 62, Issue 3, 1996, Pages 364-370

  Falkenhain, M E ^a   Cosio, F G ^a   Sedmak, D D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; KIDNEY INJURY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0029795281     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608150-00011     Document Type: Article

References (21)

1. Powell-Jackson PR, Young B, Calne RY, Williams R. Nephrotoxicity of parenterally administered cyclosporine after orthotopic liver transplantation. Transplantation 1983; 36: 505.
2. Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590.
3. Gonwa TA, Morris CA, Goldstein RM, Husbert BS, Klintmalm GB. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 1991; 51: 428.
4. Wheatley HC, Datzman M, Williams JW, Miles DE, Hatch FE. Long-term effects of cyclosporine on renal function in liver transplant recipients. Transplantation 1987; 43: 641.
5. Almond PS, Gillingham KJ, Sibley R, et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992; 53: 316.
6. Burke JF, Pirsch JD, Ramos EL, et al. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994; 331: 358.
7. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991; 2 (suppl 1): S45.
8. Palestine AG, Austin HA, Balow JE. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 1986; 314: 1293.
9. Svenson K, Bohman SO, Hallgren R. Renal interstitial fibrosis and vascular changes. Arch Intern Med 1986; 146: 2007.
10. Mihatsch M, Thiel G, Spichtin H, et al. Morphologic findings in kidney transplants after treatment with cyclosporine. Transplant Proc 1983; 15 (suppl 1): 2821.
11. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
12. Ewel CH, Foegh ML. Chronic graft rejection: accelerated transplant arteriosclerosis. Immunol Rev 1993; 134: 21.
13. Cotran RS, Kumar V, Robins SL, Eds. The Kidney. In: Robin's pathologic basis of disease. Philadelphia: WB Saunders, 1992: 1011.
14. Bertani T, Ferrazzi P, Schieppati A, et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991; 243: 250.
15. Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E. Renal histology in polycystic kidney disease with incipient and advance renal failure. Kidney Int 1992; 42: 1259.
16. Harris RD, Steffes MW, Bilous RW, Sutherland DER, Mauer SM. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 1991; 40: 107.
17. Vathsala A, Verani R, Schoenberg L, et al. Proteinuria in cyclosporine-treated renal transplant recipients. Transplantation 1990; 49: 35.
18. Lewis RM, Verani RR, Vo C, et al. Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplant native kidney histologic evaluation. J Heart Lung Transplant 1994; 13: 376.
19. Mason J, Muller-Schweinitzer E, Dupont M, et al. Cyclosporine and the renin-angiotensin system. Kidney Int 1991; 32: S28.
20. Ahuja S, Danielpour D, Balow J, Boumpas D. Cyclosporine enhance transforming growth factor β1 secretion from activated human T cells by transcriptional and post transcriptional mechanisms [Abstract]. J Am Soc Nephrol 1993; 4: 909.
21. Hostetter T, Olsen J, Rennke H, Venkatachalam M, Breener B. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85.